XSHE
300641
Market cap1.12bUSD
Jul 10, Last price
14.57CNY
1D
0.97%
1Q
-22.83%
IPO
45.70%
Name
Jiangsu Zhengdan Chemical Industry Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiangsu Zhengdan Chemical Industry Co., Ltd. operates in China, focusing on the development, manufacturing, and sale of eco-friendly materials and specialized chemical products. Its diverse product lineup includes vinyltoluene, a blend of m-methylstyrene and p-methylstyrene, vital for impregnating insulation paints, various coatings, and composite materials. The company also supplies high-flash aromatic naphthas, which are versatile and serve multiple functions: as a solvent and thinning agent in environmentally conscious paints and coatings, an ingredient in printing inks, an extracting agent for hydrogen peroxide synthesis, a solvent for baking finishes, an emulsifier in insecticides, and a solvent for rubber resins. Furthermore, Jiangsu Zhengdan offers trimellitic anhydride, available in both flake and pastille forms. This compound is a critical precursor for producing plasticizers like trioctyl trimellitate (TOTM), polyester resins used in powder coatings, polyamide-imide resins for insulating varnishes, aqueous alkyd resin coatings, epoxy curing agents, and lubricants. Trioctyl trimellitate (TOTM) itself is a robust, heat-resistant plasticizer widely incorporated into materials such as vinyl chloride copolymers, nitrocellulose, ethyl cellulose, and polymethyl methacrylate. Lastly, the company provides pseudocumene, an essential component for synthesizing trimellitic anhydride, various resins, dyes, and vitamin E, in addition to its use as a paint solvent. Founded in 2007, the company's operations are headquartered in Zhenjiang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||